Stacy's Aplastic Anemia Journey continues
Part 2: Immunotherapy begins!
Please make a donation to the Aplastic Anemia and MDS International Foundation.
Donate Today
Part 2: Immunotherapy begins!
This new series will follow Stacy as she navigates the world of bone marrow failure disease. We’ll release each new chapter as she shares what she experiences. Watch for announcements and updates!
Part 1: Symptoms and diagnosis
MDS - My Story . . . so far
As a girl in South Africa, I was healthy and active. I started college at the University of Limpopo, studying Business/Accounting in 2011.
Ravulizumab-cwvz Ravulizumab-cwvz: Ravulizumab-cwvz (Ultomiris®) is a drug approved by the U.S. Food and Drug Administration (FDA) in 2018 to treat PNH.